COMMUNIQUÉS West-GlobeNewswire

Alaunos Reports Broad Metabolic Improvements with ALN1003 in Obese Mouse Studies
26/05/2026
ALN1003 demonstrated consistent, favorable effects across key drivers of metabolic disease, including reductions in body weight and fat mass, improved insulin sensitivity, enhanced adipose function, and improved liver [...]
Affordable GLP-1 Telehealth Platform Ozari Health Announces New Industry-Wide Research Analysis on GLP-1 Pricing Data
26/05/2026
Ozari Health publishes first-of-its-kind pricing analysis to help patients understand the real cost of GLP-1 medications. New York, NY, May 26, 2026 (GLOBE NEWSWIRE) -- Ozari Health , the New York-based telehealth [...]
IBA – ACQUISITION OF OWN SHARES
26/05/2026
Louvain-la-Neuve, Belgium, May 26 th , 2026 – 6 PM CEST – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) [...]
IBA – ACQUISITION D’ACTIONS PROPRES
26/05/2026
Louvain-la-Neuve, Belgique, 26 mai 2026 – 18h00 – Conformément à l'article 8:4 de l'arrêté royal du 29 avril 2019 portant exécution du Code belge des sociétés et associations, Ion Beam Applications SA ("IBA") communique [...]
Comprehensive Healthcare launches Comprehensive Mobile Unit in Ellensburg
26/05/2026
New mobile unit expands opioid treatment access to Kittitas County YAKIMA, Wash., May 26, 2026 (GLOBE NEWSWIRE) -- Comprehensive Healthcare is bringing life-saving opioid treatment to Kittitas County with the launch of [...]
SBC Medical will participate in several upcoming investor conferences in May and June 2026
26/05/2026
IRVINE, Calif., May 26, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Medical Services Organization providing management support across a wide range [...]
Zealand Pharma - Transactions related to share buy-back program (week 21, 2026)
26/05/2026
Company announcement No. 18 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 21, 2026) Copenhagen, Denmark, May 26, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL [...]
Visory Health Announces Two Senior Executives’ Promotions Amid Rapid Growth
26/05/2026
With more than 25 years of combined experience in enterprise expansion, security and innovation, the new Chief Growth Officer and Chief Technology Officer signal continued momentum as Visory Health builds on its [...]
Novo Nordisk A/S - share repurchase programme
26/05/2026
Bagsværd, Denmark, 26 May 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) [...]
Resolutions from Zealand Pharma's Extraordinary General Meeting 2026
26/05/2026
Company announcement – No. 17 / 2026 Resolutions from Zealand Pharma's Extraordinary General Meeting 2026 Copenhagen, Denmark, May 26, 2026 - Zealand Pharma A/S ("Zealand Pharma" or the “Company”) (Nasdaq: ZEAL) (CVR-no [...]
Ionetix Announces Approval of Abbreviated New Drug Application for Gallium Ga-68 Gozetotide (PSMA-11)
26/05/2026
Leading particle accelerator company expands portfolio of positron emission tomography diagnostics LANSING, Mich., May 26, 2026 (GLOBE NEWSWIRE) -- Ionetix Corporation (“Ionetix”), a leading particle accelerator company [...]
BioRestorative Completes Phase 2 Dosing of BRTX-100, Advancing Lead Regenerative Spine Program Toward 2027 Topline Data
26/05/2026
Fully enrolled, randomized, double-blind, sham-controlled Phase 2 study has completed treatment administration in 99 patients; Company continues Phase 3 readiness activities following FDA Type B meeting alignment [...]
Microbot Medical® Receives Its First International Regulatory Approval for the Commercialization of the LIBERTY® Endovascular Robotic System
26/05/2026
Israel becomes the second jurisdiction and the first outside of the U.S. to grant marketing clearance for the LIBERTY System The AMAR regulatory approval will enable the Company to obtain a Free Sale Certificate to [...]
AiM Medical Robotics Announces Collaboration Agreement with Siemens Healthineers to Advance MRI-Guided Robotic Neurosurgery
26/05/2026
Worcester, MA, May 26, 2026 (GLOBE NEWSWIRE) -- AiM Medical Robotics, a leading developer of advanced robotic systems for MRI-guided neurosurgery, today announced a collaboration agreement with Siemens Healthineers for [...]
Clearmind Medicine Announces Johns Hopkins IRB Approval to Advance CMND-100 Phase I/II Clinical Trial to the Next Parts
26/05/2026
Vancouver, Canada, May 26, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel, non- [...]
60 Degrees Pharmaceuticals Announces Early Enrollment of First Seasonal Patient in Clinical Trial of Tafenoquine for Patients Hospitalized with Babesiosis
26/05/2026
Enrollment is tracking ahead of schedule, allowing potential acceleration of key trial milestones Minimum enrollment to support interim analysis expected as soon as early July 2026 Randomized, double-blind, placebo- [...]
Nu-Tek BioSciences accélère la révolution des matières premières sans origine animale et rejoint le pavillon du Minnesota #4507 au salon BIO 2026
26/05/2026
Nu-Tek BioSciences rejoint le pavillon du Minnesota organisé par le Minnesota Department of Employment and Economic Development (MN DEED) lors du salon BIO, du 22 au 25 juin à San Diego, en Californie, afin de présenter [...]
Nu-Tek BioSciences Fuels Animal-Free Raw Materials Revolution, Joins Minnesota Pavilion #4507 at BIO 2026
26/05/2026
Nu-Tek BioSciences joins the MN DEED Minnesota Pavilion at BIO, June 22-25 in San Diego, CA, offering biotech innovators a blueprint for scalable, animal-free manufacturing through its product portfolio and Variability [...]
MBX Biosciences to Present at the Jefferies 2026 Global Healthcare Conference in New York City
26/05/2026
CARMEL, Ind. and BURLINGTON, Mass., May 26, 2026 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel [...]

Pages